Myovant Sciences Ltd. (MYOV)
NYSE: MYOV
· Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM
Myovant Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -57.63M | -45.62M | -21.24M | -59.28M | -63.45M | -21.59M | -61.66M | -81.36M | -73.85M | -67.06M | -32.86M |
Depreciation & Amortization | 882K | 810K | 795K | 760K | 776K | 812K | 724K | 692K | 641K | 595K | 551K |
Stock-Based Compensation | 10.98M | 11.72M | 9.71M | 8.6M | 7.2M | 11.86M | 11.26M | 31.93M | 7.01M | 6.92M | 7.81M |
Other Working Capital | -47.11M | 49.35M | -43.44M | -45.59M | -35.78M | 51.51M | -46.83M | -50.23M | 640.7M | 15.75M | -24.07M |
Other Non-Cash Items | n/a | n/a | 568K | 596K | 617K | 609K | 601K | 596K | -5.71M | -6.42M | -3.48M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -57.13M | 42.21M | -65.83M | -50.76M | -37.04M | 44.91M | -64.1M | -44.8M | 646.05M | 17.37M | -34.01M |
Operating Cash Flow | -102.9M | 9.12M | -76M | -100.09M | -91.89M | 36.6M | -113.18M | -92.94M | 574.15M | -48.59M | -61.98M |
Capital Expenditures | -228K | -314K | -72K | -251K | -362K | -361K | n/a | -737K | -302K | -583K | -151K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -217K | -14.48M | -10.17M | 89K | -24.39M | -16.02M | -78.43M | -16.26M | -18.69M | -13.9M | -14.97M |
Sales Maturities Of Investments | 5.7M | 18.3M | 4.5M | 42.45M | 52.22M | 3M | 4.04M | 38.15M | 3.45M | 11.79M | 3M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 5.25M | 3.51M | -5.74M | 42.29M | 27.47M | -13.38M | -74.39M | 21.15M | -15.54M | -2.7M | -12.12M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.57M | 3.95M | 1.19M | 6.76M | 4.01M | 11M | 4.13M | 32.76M | 61.71M | 61.39M | 82.19M |
Financial Cash Flow | 1.57M | 3.95M | 1.19M | 6.76M | 4.01M | 11M | 4.13M | 32.76M | 61.71M | 61.39M | 82.19M |
Net Cash Flow | -96.07M | 16.58M | -80.56M | -51.04M | -60.42M | 34.22M | -183.43M | -39.03M | 620.31M | 10.1M | 8.08M |
Free Cash Flow | -103.13M | 8.81M | -76.08M | -100.34M | -92.26M | 36.24M | -113.18M | -93.68M | 573.85M | -49.17M | -62.13M |